Completed PHASE3 INTERVENTIONAL 2-arm NCT03331588

Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung Cancer

Comparison Study of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal Vedio-assisted Thoracic Surgery for Radical Lung Cancer Resection

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China

Conditions Carcinoma, Bronchogenic Carcinoma, Non-Small-Cell Lung Lung Diseases Lung Neoplasms Thoracic Neoplasm Thoracic Surgery

Interventions Intercostal uniportal VATS Subxiphoid uniportal VATS

Updated 7 times since 2017 Last updated: Feb 28, 2020 Started: Nov 10, 2017 Primary completion: Feb 28, 2020 Completion: Feb 28, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Carcinoma, Bronchogenic and Carcinoma, Non-Small-Cell Lung, this trial is completed. The trial is conducted by Shanghai Pulmonary Hospital, Shanghai, China and has accumulated 7 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Apr 2020 — Jan 2021 [monthly]

Completed PHASE3

Status: Recruiting → Completed
May 2019 — Apr 2020 [monthly]

Recruiting PHASE3

▶ Show 2 earlier versions

Jun 2018 — May 2019 [monthly]

Recruiting PHASE3
Dec 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

Nov 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai Pulmonary Hospital, Shanghai, China

Data source: Shanghai Pulmonary Hospital, Shanghai, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China